New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 29, 2013
11:28 EDTRDYDr. Reddy's announces the launch of Zenatane
Dr. Reddy’s Laboratories announced that it has launched Zenatane, Isotretinoin Capsules USP, in 20 mg and 40 mg, a therapeutically equivalent generic version of Accutane, Isotretinoin Capsules USP, in the US market on March 28, 2013 following the approval by the United States Food & Drug Administration, USFDA, of Dr. Reddy’s ANDA for Zenatane™ 10 mg, 20 mg and 40 mg. The total market had U.S. sales of approximately $309 Million for the most recent twelve months ending January 2013 according to IMS Health*. Dr. Reddy’s Zenatane™ Capsules 10 mg, 20 mg, & 40 mg will be available in boxes of 30, 3 prescription packs of 10 capsules, as unit dose blisters.
News For RDY From The Last 14 Days
Check below for free stories on RDY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for RDY

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use